Who are the key players in the Sotorasib Tablets Market Report 2026 market?

Major companies operating in the Sotorasib Tablets Market Report 2026 market are Major companies operating in the sotorasib tablets market are Amgen Inc. Read More

Sotorasib Tablets Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Sotorasib Tablets Market Report 2026

Name: Sotorasib Tablets Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Dosage Form (40 Milligrams (Mg) Tablets, 120 Milligrams (Mg) Tablets, 240 Milligrams (Mg) Tablets, Other Dosage Forms), By Patient Demographics (Adolescents, Adult, Senior Adults), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels), By Application (Non-Small Cell Lung Cancer, Colorectal Cancer, Other Applications), By End-User (Hospitals, Oncology Centers, Clinics, Other End-Users) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Sotorasib Tablets Market Overview

• Sotorasib Tablets market size has reached to $1.92 billion in 2025

• Expected to grow to $3.4 billion in 2030 at a compound annual growth rate (CAGR) of 12%

• Growth Driver: Rising Prevalence Of Cancer Fueling The Market Growth Due To Increasing Life Expectancy

• Market Trend: Combination Therapies Show Promise In Extending Progression-Free Survival In Advanced Cancers

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Sotorasib Tablets Market?

Sotorasib tablets are a prescription medicine developed for the treatment of certain cases of non-small cell lung cancer in patients whose tumors carry the KRAS G12C gene mutation. The medicine works by binding to the abnormal KRAS protein, preventing it from sending signals that drive the uncontrolled growth and survival of cancer cells. This targeted inhibition can reduce tumor activity, slow disease progression, and improve treatment outcomes in patients who have limited options with standard therapies.

The main dosage forms of sotorasib tablets are 40 milligrams (mg), 120 milligrams (mg), 240 milligrams (mg), and other dosage forms. The 40 mg tablets are a lower-strength form of the KRAS G12C inhibitor Lumakras, enabling precise dose adjustments for improved safety and tolerability. Sotorasib is used in patient populations including adolescents, adults, and senior adults. It is distributed through various channels, such as hospital pharmacies, retail pharmacies, online pharmacies, and other distribution channels, and is used for applications including non-small cell lung cancer, colorectal cancer, and other indications. The end-users include hospitals, oncology centers, clinics, and other healthcare providers.

Sotorasib Tablets Market Global Report 2026 Market Report bar graph

What Is The Sotorasib Tablets Market Size and Share 2026?

The sotorasib tablets market size has grown rapidly in recent years. It will grow from $1.92 billion in 2025 to $2.16 billion in 2026 at a compound annual growth rate (CAGR) of 12.3%. The growth in the historic period can be attributed to increasing diagnosis of non-small cell lung cancer, advancements in kras mutation research, regulatory approvals for targeted oncology drugs, expansion of molecular diagnostic capabilities, growth in oncology clinical trials.

What Is The Sotorasib Tablets Market Growth Forecast?

The sotorasib tablets market size is expected to see rapid growth in the next few years. It will grow to $3.4 billion in 2030 at a compound annual growth rate (CAGR) of 12.0%. The growth in the forecast period can be attributed to increasing development of next-generation kras inhibitors, rising combination therapy approaches, expansion of targeted treatments into additional cancer indications, growing use of real-world evidence studies, increasing oncology precision medicine adoption. Major trends in the forecast period include increasing adoption of kras g12c inhibitor therapies, rising focus on targeted lung cancer treatments, growing use of oral oncology medications, expansion of companion diagnostic testing, enhanced monitoring of resistance mechanisms.

Book your 30 minutes free consultation with our research experts

Global Sotorasib Tablets Market Segmentation

1) By Dosage Form: 40 Milligrams (Mg) Tablets, 120 Milligrams (Mg) Tablets, 240 Milligrams (Mg) Tablets, Other Dosage Forms

2) By Patient Demographics: Adolescents, Adult, Senior Adults

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels

4) By Application: Non-Small Cell Lung Cancer, Colorectal Cancer, Other Applications

5) By End-User: Hospitals, Oncology Centers, Clinics, Other End-Users

What Are The Drivers Of The Sotorasib Tablets Market?

The rising prevalence of cancer is expected to propel the growth of the sotorasib tablets market going forward. Cancer is a group of diseases where abnormal cells grow uncontrollably, invade tissues, and can spread to other parts of the body. The increasing cancer prevalence is due to aging population, as advanced age is the most significant risk factor for developing most types of cancer, with the majority of cases occurring in individuals over 65 years old. Sotorasib tablets work by selectively and irreversibly targeting the KRAS G12C mutation, permanently locking the mutated protein in the off position to prevent uncontrolled cell growth in patients with advanced solid tumors, particularly non-small cell lung cancer. For instance, in February 2024, according to the World Health Organization, a Switzerland-based international organization specializing in global health policy and public health initiatives, over 35 million new cancer cases are predicted in 2050, a 77% increase from the estimated 20 million cases in 2022. Therefore, the rising prevalence of cancer is driving the growth of the sotorasib tablets industry.

The rising geriatric population is expected to propel the growth of the sotorasib tablets market going forward. The geriatric population refers to the group of older adults, typically aged 65 years and above, who may experience age-related physiological, psychological, and social changes. The rising geriatric population is primarily due to increased life expectancy, as advancements in healthcare, nutrition, and living conditions allow more people to live longer, resulting in a higher proportion of older adults in the population. Sotorasib tablets help the geriatric population by targeting KRAS G12C-mutated cancers, offering a precision therapy that addresses age-related vulnerabilities and improves treatment outcomes in older adults. For instance, in July 2024, according to the UK Parliament's House of Commons Library, a UK-based government administration, in 2022, there were 12.7 million people aged 65 or older in the UK, representing 19% of the total population. This number is projected to rise to 22.1 million by 2072, accounting for 27% of the population. Therefore, the rising geriatric population is driving the growth of the sotorasib tablets industry.

Key Players In The Global Sotorasib Tablets Market

Major companies operating in the sotorasib tablets market are Amgen Inc.

Global Sotorasib Tablets Market Trends and Insights

Major companies operating in the sotorasib tablets market are focusing on developing innovative therapies such as combination treatments to improve efficacy and overcome resistance. Combination treatments refer to using two or more drugs together to target cancer through multiple mechanisms simultaneously, helping to increase treatment effectiveness, overcome or delay drug resistance, reduce the likelihood of cancer recurrence, and improve overall patient outcomes and quality of life. For instance, in January 2025, Amgen Inc., a US-based biotechnology company, received U.S. Food and Drug Administration (FDA) approval for sotorasib in combination with panitumumab for the treatment of adult patients with KRAS G12C–mutated metastatic colorectal cancer (mCRC) who had previously received standard chemotherapy. This approval was based on the results of the Phase 3 CodeBreaK 300 study, which demonstrated that the combination more than doubled progression-free survival compared to the investigator’s choice of standard-of-care therapy, providing a significant new option for patients with this difficult-to-treat cancer. Sotorasib is a first-in-class, oral KRAS G12C inhibitor that works by selectively targeting and locking the mutant KRAS protein in its inactive state, thereby blocking cancer cell growth and signaling pathways driven by this mutation.

Need data on a specific region in this market?

Request Regional Data

Regional Insights

North America was the largest region in the sotorasib tablets market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Sotorasib Tablets Market?

The sotorasib tablets market consists of sales of lumakras, lumykras, and diagnostic companion kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Sotorasib Tablets Market Report 2026?

The sotorasib tablets market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the sotorasib tablets industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Sotorasib Tablets Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$2.16 billion
Revenue Forecast In 2035	$3.4 billion
Growth Rate	CAGR of 12.3% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Dosage Form, Patient Demographics, Distribution Channel, Application, End-User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Amgen Inc.
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Sotorasib Tablets Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Sotorasib Tablets Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Sotorasib Tablets Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Sotorasib Tablets Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Fintech, Blockchain, Regtech & Digital Finance

4.2. Major Trends

4.2.1 Increasing Adoption Of KRAS G12C Inhibitor Therapies

4.2.2 Rising Focus On Targeted Lung Cancer Treatments

4.2.3 Growing Use Of Oral Oncology Medications

4.2.4 Expansion Of Companion Diagnostic Testing

4.2.5 Enhanced Monitoring Of Resistance Mechanisms

5. Sotorasib Tablets Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Oncology Centers

5.3 Specialty Clinics

5.4 Research Institutes

5.5 Pharmaceutical Companies

6. Sotorasib Tablets Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Sotorasib Tablets Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Sotorasib Tablets PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Sotorasib Tablets Market Size, Comparisons And Growth Rate Analysis

7.3. Global Sotorasib Tablets Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Sotorasib Tablets Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Sotorasib Tablets Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Sotorasib Tablets Market Segmentation

9.1. Global Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

40 Milligrams (Mg) Tablets, 120 Milligrams (Mg) Tablets, 240 Milligrams (Mg) Tablets, Other Dosage Forms

9.2. Global Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Adolescents, Adult, Senior Adults

9.3. Global Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels

9.4. Global Sotorasib Tablets Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Non-Small Cell Lung Cancer, Colorectal Cancer, Other Applications

9.5. Global Sotorasib Tablets Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Oncology Centers, Clinics, Other End-Users

10. Sotorasib Tablets Market Regional And Country Analysis

10.1. Global Sotorasib Tablets Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Sotorasib Tablets Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Sotorasib Tablets Market

11.1. Asia-Pacific Sotorasib Tablets Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Sotorasib Tablets Market, Segmentation By Dosage Form, Segmentation By Patient Demographics, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Sotorasib Tablets Market

12.1. China Sotorasib Tablets Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Sotorasib Tablets Market, Segmentation By Dosage Form, Segmentation By Patient Demographics, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Sotorasib Tablets Market

13.1. India Sotorasib Tablets Market, Segmentation By Dosage Form, Segmentation By Patient Demographics, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Sotorasib Tablets Market

14.1. Japan Sotorasib Tablets Market Overview

14.2. Japan Sotorasib Tablets Market, Segmentation By Dosage Form, Segmentation By Patient Demographics, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Sotorasib Tablets Market

15.1. Australia Sotorasib Tablets Market, Segmentation By Dosage Form, Segmentation By Patient Demographics, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Sotorasib Tablets Market

16.1. Indonesia Sotorasib Tablets Market, Segmentation By Dosage Form, Segmentation By Patient Demographics, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Sotorasib Tablets Market

17.1. South Korea Sotorasib Tablets Market Overview

17.2. South Korea Sotorasib Tablets Market, Segmentation By Dosage Form, Segmentation By Patient Demographics, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Sotorasib Tablets Market

18.1. Taiwan Sotorasib Tablets Market Overview

18.2. Taiwan Sotorasib Tablets Market, Segmentation By Dosage Form, Segmentation By Patient Demographics, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Sotorasib Tablets Market

19.1. South East Asia Sotorasib Tablets Market Overview

19.2. South East Asia Sotorasib Tablets Market, Segmentation By Dosage Form, Segmentation By Patient Demographics, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Sotorasib Tablets Market

20.1. Western Europe Sotorasib Tablets Market Overview

20.2. Western Europe Sotorasib Tablets Market, Segmentation By Dosage Form, Segmentation By Patient Demographics, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Sotorasib Tablets Market

21.1. UK Sotorasib Tablets Market, Segmentation By Dosage Form, Segmentation By Patient Demographics, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Sotorasib Tablets Market

22.1. Germany Sotorasib Tablets Market, Segmentation By Dosage Form, Segmentation By Patient Demographics, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Sotorasib Tablets Market

23.1. France Sotorasib Tablets Market, Segmentation By Dosage Form, Segmentation By Patient Demographics, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Sotorasib Tablets Market

24.1. Italy Sotorasib Tablets Market, Segmentation By Dosage Form, Segmentation By Patient Demographics, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Sotorasib Tablets Market

25.1. Spain Sotorasib Tablets Market, Segmentation By Dosage Form, Segmentation By Patient Demographics, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Sotorasib Tablets Market

26.1. Eastern Europe Sotorasib Tablets Market Overview

26.2. Eastern Europe Sotorasib Tablets Market, Segmentation By Dosage Form, Segmentation By Patient Demographics, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Sotorasib Tablets Market

27.1. Russia Sotorasib Tablets Market, Segmentation By Dosage Form, Segmentation By Patient Demographics, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Sotorasib Tablets Market

28.1. North America Sotorasib Tablets Market Overview

28.2. North America Sotorasib Tablets Market, Segmentation By Dosage Form, Segmentation By Patient Demographics, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Sotorasib Tablets Market

29.1. USA Sotorasib Tablets Market Overview

29.2. USA Sotorasib Tablets Market, Segmentation By Dosage Form, Segmentation By Patient Demographics, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Sotorasib Tablets Market

30.1. Canada Sotorasib Tablets Market Overview

30.2. Canada Sotorasib Tablets Market, Segmentation By Dosage Form, Segmentation By Patient Demographics, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Sotorasib Tablets Market

31.1. South America Sotorasib Tablets Market Overview

31.2. South America Sotorasib Tablets Market, Segmentation By Dosage Form, Segmentation By Patient Demographics, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Sotorasib Tablets Market

32.1. Brazil Sotorasib Tablets Market, Segmentation By Dosage Form, Segmentation By Patient Demographics, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Sotorasib Tablets Market

33.1. Middle East Sotorasib Tablets Market Overview

33.2. Middle East Sotorasib Tablets Market, Segmentation By Dosage Form, Segmentation By Patient Demographics, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Sotorasib Tablets Market

34.1. Africa Sotorasib Tablets Market Overview

34.2. Africa Sotorasib Tablets Market, Segmentation By Dosage Form, Segmentation By Patient Demographics, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Sotorasib Tablets Market Regulatory and Investment Landscape

36. Sotorasib Tablets Market Competitive Landscape And Company Profiles

36.1. Sotorasib Tablets Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Sotorasib Tablets Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Sotorasib Tablets Market Company Profiles

36.3.1. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Global Sotorasib Tablets Market Competitive Benchmarking And Dashboard

38. Key Mergers And Acquisitions In The Sotorasib Tablets Market

39. Sotorasib Tablets Market High Potential Countries, Segments and Strategies

39.1 Sotorasib Tablets Market In 2030 - Countries Offering Most New Opportunities

39.2 Sotorasib Tablets Market In 2030 - Segments Offering Most New Opportunities

39.3 Sotorasib Tablets Market In 2030 - Growth Strategies

39.3.1 Market Trend Based Strategies

39.3.2 Competitor Strategies

40. Appendix

40.1. Abbreviations

40.2. Currencies

40.3. Historic And Forecast Inflation Rates

40.4. Research Inquiries

40.5. The Business Research Company

40.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Sotorasib Tablets Market, Overview Of Key Products - Product Examples

Table 2: Global Sotorasib Tablets Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Sotorasib Tablets Market, Supply Chain Analysis

Table 4: Global Sotorasib Tablets Market, Major Raw Material Providers

Table 5: Global Sotorasib Tablets Market, Major Resource Providers

Table 6: Global Sotorasib Tablets Market, Major Manufacturers (Suppliers)

Table 7: Global Sotorasib Tablets Market, Major Distributors And Channel Partners

Table 8: Global Sotorasib Tablets Market, Key Technologies & Future Trends

Table 9: Global Sotorasib Tablets Market, Major Trends

Table 10: Global Sotorasib Tablets Market, Major End Users

Table 11: Global Sotorasib Tablets Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Sotorasib Tablets Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Sotorasib Tablets Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Sotorasib Tablets Market - TAM, US$ Billion, 2025

Table 15: Global Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Sotorasib Tablets Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Sotorasib Tablets Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Sotorasib Tablets Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Sotorasib Tablets Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Asia-Pacific, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Asia-Pacific, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: China, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: China, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: India, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: India, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: Japan, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: Japan, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Australia, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Australia, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Indonesia, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Indonesia, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: South Korea, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: South Korea, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: Taiwan, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: Taiwan, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: South East Asia, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: South East Asia, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: Western Europe, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: Western Europe, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: UK, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: UK, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: Germany, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: Germany, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: France, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: France, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: Italy, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: Italy, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Spain, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Spain, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Eastern Europe, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Eastern Europe, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Russia, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Russia, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: North America, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: North America, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: USA, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: USA, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: Canada, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: Canada, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: South America, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: South America, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: Brazil, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: Brazil, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Middle East, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Middle East, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Africa, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Africa, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Global Sotorasib Tablets Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 95: Global Sotorasib Tablets Market - Company Scoring Matrix

Table 96: Amgen Inc. Financial Performance

Table 97: Global Sotorasib Tablets Market, Competitive Benchmarking (In USD Billions)

Table 98: Global Sotorasib Tablets Market, Competitive Dashboard

Table 99: Global Sotorasib Tablets Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 100: Global, Sotorasib Tablets Market Size Gain ($ Billion), Segmentation By Dosage Form, 2025 – 2030

Table 101: Global, Sotorasib Tablets Market Size Gain ($ Billion), Segmentation By Patient Demographics, 2025 – 2030

Table 102: Global, Sotorasib Tablets Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

List Of Figures

Figure 1: Global Sotorasib Tablets Market, Overview Of Key Products - Product Examples

Figure 2: Global Sotorasib Tablets Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Sotorasib Tablets Market, Supply Chain Analysis

Figure 4: Global Sotorasib Tablets Market, Major Raw Material Providers

Figure 5: Global Sotorasib Tablets Market, Major Resource Providers

Figure 6: Global Sotorasib Tablets Market, Major Manufacturers (Suppliers)

Figure 7: Global Sotorasib Tablets Market, Major Distributors And Channel Partners

Figure 8: Global Sotorasib Tablets Market, Key Technologies & Future Trends

Figure 9: Global Sotorasib Tablets Market, Major Trends

Figure 10: Global Sotorasib Tablets Market, Major End Users

Figure 11: Global Sotorasib Tablets Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Sotorasib Tablets Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Sotorasib Tablets Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Sotorasib Tablets Market - TAM, US$ Billion, 2025

Figure 15: Global Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Sotorasib Tablets Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Sotorasib Tablets Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Sotorasib Tablets Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Sotorasib Tablets Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Asia-Pacific, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Asia-Pacific, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: China, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: China, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: India, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: India, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: Japan, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: Japan, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Australia, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Australia, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Indonesia, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Indonesia, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: South Korea, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: South Korea, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: Taiwan, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: Taiwan, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: South East Asia, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: South East Asia, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: Western Europe, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: Western Europe, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: UK, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: UK, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: Germany, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: Germany, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: France, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: France, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: Italy, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: Italy, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Spain, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Spain, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Eastern Europe, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Eastern Europe, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Russia, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Russia, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: North America, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: North America, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: USA, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: USA, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: Canada, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: Canada, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: South America, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: South America, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: Brazil, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: Brazil, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Middle East, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Middle East, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Africa, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Africa, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Global Sotorasib Tablets Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 95: Global Sotorasib Tablets Market - Company Scoring Matrix

Figure 96: Amgen Inc. Financial Performance

Figure 97: Global Sotorasib Tablets Market, Competitive Benchmarking (In USD Billions)

Figure 98: Global Sotorasib Tablets Market, Competitive Dashboard

Figure 99: Global Sotorasib Tablets Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 100: Global, Sotorasib Tablets Market Size Gain ($ Billion), Segmentation By Dosage Form, 2025 – 2030

Figure 101: Global, Sotorasib Tablets Market Size Gain ($ Billion), Segmentation By Patient Demographics, 2025 – 2030

Figure 102: Global, Sotorasib Tablets Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Ashwagandha Extract Market Report 2026 - Global Outlook – By Type (Immunity Health, Stress And Anxiety, General Health ), By Form (Powder, Capsules Or Tablets, Other Forms), By Distribution Channel (Business To Business,...

Cholinergic Drugs Market Report 2026 - Global Outlook – By Type (Powder, Tablet, Capsule), By Drug Type (Muscarinic Agonists, Nicotinic Agonists, Acetylcholinesterase Inhibitors), By Indication (Alzheimer's Disease, Myas...

Effervescent Tablet Market Report 2026 - Global Outlook – By Product (Medication, Supplements), By Methods (Dry Methods, Wet Granulation), By Indication (Diuretics, Pain Management, Gastric Disorders, Respiratory Disease...

Tea Capsule Market Report 2026 - Global Outlook – By Product Type (Red Tea Capsules, Oolong Tea Capsules, Black Tea Capsules, Yellow Tea Capsules, Other Product Types ), By Distribution Channel (Hypermarkets And Supermar...

Methenamine Hippurate Tablets Market Report 2026 - Global Outlook – By Type (20 Tablets Or Bottle, 6 Tablets Or Bottle), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), By Application (Unco...

Herbal Medicine Market Report 2026 - Global Outlook – By Product (Capsules And Tablets, Powders, Extracts, Syrups, Other Products), By Category (Herbal Pharmaceuticals, Herbal Functional Foods, Herbal Dietary Supplements...

Medicinal Mushroom Market Report 2026 - Global Outlook – By Type (Shiitake, Reishi, Maitake, Chaga, Cordyceps, Turkey Tail, Other Types), By Form (Fresh, Dried, Other Forms), By Application (Antioxidants, Immune Enhancer...

Frequently Asked Questions

How big is the Sotorasib Tablets Market?

The Sotorasib Tablets market was valued at $1.92 billion in 2025, increased to $2.16 billion in 2026, and is projected to reach $3.4 billion by 2030.

What is the Sotorasib Tablets market growth?

The global Sotorasib Tablets market is expected to grow at a CAGR of 12.0% from 2026 to 2035 to reach $3.4 billion by 2035.

Who are the key players in Sotorasib Tablets market?

Some Key Players in the Sotorasib Tablets market Include, Amgen Inc. .

What is the anticipated growth trend for the Sotorasib Tablets market?

Major trend in this market includes: Combination Therapies Show Promise In Extending Progression-Free Survival In Advanced Cancers. For further insights on this market. request a sample here

Which region has the most growth potential in the Sotorasib Tablets market?

North America was the largest region in the sotorasib tablets market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sotorasib tablets market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.